BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31244850)

  • 1. Role of Dendritic Cells in Natural Immune Control of HIV-1 Infection.
    Martin-Gayo E; Yu XG
    Front Immunol; 2019; 10():1306. PubMed ID: 31244850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells.
    Cardinaud S; Urrutia A; Rouers A; Coulon PG; Kervevan J; Richetta C; Bet A; Maze EA; Larsen M; Iglesias MC; Appay V; Graff-Dubois S; Moris A
    Eur J Immunol; 2017 May; 47(5):818-829. PubMed ID: 28266028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic Cell Immune Responses in HIV-1 Controllers.
    Martin-Gayo E; Yu XG
    Curr HIV/AIDS Rep; 2017 Feb; 14(1):1-7. PubMed ID: 28110421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Expression of Interferon-Stimulated Genes in Response to HIV-1 Infection in Dendritic Cells Based on Their Maturation State.
    Calonge E; Bermejo M; Diez-Fuertes F; Mangeot I; González N; Coiras M; Jiménez Tormo L; García-Perez J; Dereuddre-Bosquet N; Le Grand R; Alcamí J
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1.
    Melki MT; Saïdi H; Dufour A; Olivo-Marin JC; Gougeon ML
    PLoS Pathog; 2010 Apr; 6(4):e1000862. PubMed ID: 20419158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral piracy: HIV-1 targets dendritic cells for transmission.
    Lekkerkerker AN; van Kooyk Y; Geijtenbeek TB
    Curr HIV Res; 2006 Apr; 4(2):169-76. PubMed ID: 16611055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus (HIV)-1.
    Walsh SR; Bhardwaj N; Gandhil RT
    Curr HIV Res; 2003 Apr; 1(2):205-16. PubMed ID: 15043203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells.
    Gougeon ML; Melki MT; Saïdi H
    Cell Death Differ; 2012 Jan; 19(1):96-106. PubMed ID: 22033335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Abortive HIV-1 RNAs Induce Potent Antiviral Immunity.
    Stunnenberg M; Sprokholt JK; van Hamme JL; Kaptein TM; Zijlstra-Willems EM; Gringhuis SI; Geijtenbeek TBH
    Front Immunol; 2020; 11():8. PubMed ID: 32038656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talk.
    Saïdi H; Melki MT; Gougeon ML
    PLoS One; 2008; 3(10):e3601. PubMed ID: 18974890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic Cells, the Double Agent in the War Against HIV-1.
    Martín-Moreno A; Muñoz-Fernández MA
    Front Immunol; 2019; 10():2485. PubMed ID: 31708924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetherin does not significantly restrict dendritic cell-mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef.
    Coleman CM; Spearman P; Wu L
    Retrovirology; 2011 Apr; 8():26. PubMed ID: 21504576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-lymphocyte cross talk downregulates host restriction factor SAMHD1 and stimulates HIV-1 replication in dendritic cells.
    Su B; Biedma ME; Lederle A; Peressin M; Lambotin M; Proust A; Decoville T; Schmidt S; Laumond G; Moog C
    J Virol; 2014 May; 88(9):5109-21. PubMed ID: 24574390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.
    Paquin-Proulx D; Gibbs A; Bächle SM; Checa A; Introini A; Leeansyah E; Wheelock CE; Nixon DF; Broliden K; Tjernlund A; Moll M; Sandberg JK
    J Immunol; 2016 Sep; 197(5):1843-51. PubMed ID: 27481843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells as a conduit to improve HIV vaccines.
    Pope M
    Curr Mol Med; 2003 May; 3(3):229-42. PubMed ID: 12699360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Complement Receptors (CRs) on DCs in Anti-HIV-1 Immunity.
    Posch W; Bermejo-Jambrina M; Lass-Flörl C; Wilflingseder D
    Front Immunol; 2020; 11():572114. PubMed ID: 33224139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell dysregulation during HIV-1 infection.
    Miller E; Bhardwaj N
    Immunol Rev; 2013 Jul; 254(1):170-89. PubMed ID: 23772620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells.
    Posch W; Steger M; Knackmuss U; Blatzer M; Baldauf HM; Doppler W; White TE; Hörtnagl P; Diaz-Griffero F; Lass-Flörl C; Hackl H; Moris A; Keppler OT; Wilflingseder D
    PLoS Pathog; 2015 Jun; 11(6):e1005005. PubMed ID: 26121641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition.
    Groot F; van Capel TM; Kapsenberg ML; Berkhout B; de Jong EC
    Blood; 2006 Sep; 108(6):1957-64. PubMed ID: 16705088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cells.
    Coleman CM; Gelais CS; Wu L
    Adv Exp Med Biol; 2013; 762():109-30. PubMed ID: 22975873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.